Kantarjian H

Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy

H. Kantarjian, J. Cortes, A. Quintás-Cardama, 2012, Haematologica.